Home / Import refusals / SCS-1068884-6/21/1

SCS-1068884-6/21/1

Mylan Pharmaceuticals Inc — FEI 1110315

Recent inspections

  • 1219018 (NAI Fri Aug 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1170444 (VAI Thu May 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1099590 (NAI Thu Aug 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1076082 (NAI Fri Nov 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1072148 (NAI Wed Nov 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • AEK-4732872-7/11/1 (Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-3225077-9/11/1 (Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-2783875-2/11/1 (Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-2786470-9/11/1 (Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8237854-4/21/1 (Fri Dec 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
August 14, 2020
Country
United States
Product Category
Drugs and Biologics
Product Code
66VDA99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
75